Sohonos to treat heterotopic ossification
Drug Name: Sohonos Indications: To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for…
Elrexfia to treat multiple myeloma
Drug Name: Elrexfio Indications: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. Active Ingredient: Elranatamab-bcmm Company: Pfizer Inc Approval…
Talvey to treat multiple myeloma
Drug Name: Talvey Indications: To treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. Active Ingredient: Talquetamab-tgvs Company: Janssen Pharmaceutical Companies Approval Date:…
Zurzuvae to treat postpartum depression
Drug Name: Zurzuvae Indications: To treat postpartum depression. Active Ingredient: Zuranolone Company: Biogen Inc Approval Date: 8/4/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369s000lbl.pdf
Izervay to treat macular degeneration
Drug Name: Izervay Indications: To treat geographic atrophy secondary to age-related macular degeneration. Active Ingredient: Avacincaptad pegol Company: IVERIC bio, Inc Approval Date: 8/4/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217225s000lbl.pdf
First Oral Medication to Treat Postpartum Depression
Jointly developed by Biogen and Sage Therapeutics, the oral drug, Zurzuvae (zuranolone), offers a significant advancement in postpartum depression (PPD) treatment options. PPD is a form of major depressive episode…
Xdemvy to treat Demodex blepharitis
Name: Xdemvy Indications: To treat Demodex blepharitis. Active Ingredient: Lotilaner Company: Tarsus Pharmaceuticals, Inc. Approval Date: 7/25/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217603s000lbl.pdf
Vanflyta to treat myeloid leukemia
Name: Vanflyta Indications: To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria. Active Ingredient: Quizartinib Company: Daiichi Sankyo, Inc Approval Date:…
Ngenla to treat growth failure
Drug Name: Ngenla Indications: To treat growth failure due to inadequate secretion of endogenous growth hormone. Active Ingredient: Somatrogon-ghla Company: Pfizer Inc, OPKO Health Inc Approval Date: 6/27/2023 More…
Rystiggo to treat myasthenia gravis
Drug Name: Rystiggo Indications: To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive. Active Ingredient: Rozanolixizumab-noli Company: UCB, Inc Approval Date: 6/26/2023 More…